Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,917 | 527 | 97.2% |
| Education | $289.50 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,439 | 70 | $0 (2024) |
| ABBVIE INC. | $1,390 | 81 | $0 (2024) |
| Janssen Biotech, Inc. | $991.43 | 43 | $0 (2024) |
| UCB, Inc. | $843.88 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $625.04 | 8 | $0 (2024) |
| Horizon Therapeutics plc | $612.10 | 43 | $0 (2023) |
| Genentech USA, Inc. | $436.33 | 24 | $0 (2024) |
| Lilly USA, LLC | $412.01 | 21 | $0 (2023) |
| PFIZER INC. | $412.01 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $403.64 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,170 | 51 | Janssen Biotech, Inc. ($348.23) |
| 2023 | $1,066 | 51 | ABBVIE INC. ($330.81) |
| 2022 | $2,309 | 98 | AstraZeneca Pharmaceuticals LP ($589.80) |
| 2021 | $1,407 | 81 | Amgen Inc. ($424.87) |
| 2020 | $1,435 | 84 | Amgen Inc. ($208.45) |
| 2019 | $2,455 | 148 | Janssen Pharmaceuticals, Inc ($259.61) |
| 2018 | $362.78 | 20 | UCB, Inc. ($50.10) |
All Payment Transactions
533 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Immunology | ||||||
| 11/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Immunology | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Immunology | ||||||
| 10/01/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Immunology | ||||||
| 09/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: Immunology | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/06/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: INFLIXIMAB | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 313 | 538 | $117,587 | $40,659 |
| 2022 | 14 | 478 | 847 | $141,604 | $49,481 |
| 2021 | 15 | 495 | 710 | $111,721 | $45,641 |
| 2020 | 2 | 167 | 353 | $74,445 | $31,554 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 108 | 204 | $70,584 | $23,462 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 84 | $20,580 | $7,258 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $15,688 | $6,014 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 43 | $7,525 | $2,863 | 38.0% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 15 | 25 | $1,400 | $598.40 | 42.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 22 | 33 | $1,320 | $407.55 | 30.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 70 | $280.00 | $45.20 | 16.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 42 | $210.00 | $10.99 | 5.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 91 | 151 | $52,246 | $19,146 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 170 | $41,634 | $14,074 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 52 | 52 | $22,048 | $7,859 | 35.6% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 44 | 79 | $4,424 | $1,932 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,704 | $1,764 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 28 | $4,900 | $1,327 | 27.1% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 26 | 46 | $2,484 | $1,102 | 44.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 15 | 28 | $1,512 | $708.13 | 46.8% |
| 72052 | X-ray of upper spine, 6 or more views | Office | 2022 | 11 | 11 | $1,210 | $501.40 | 41.4% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2022 | 13 | 13 | $1,183 | $414.32 | 35.0% |
| 72170 | X-ray of pelvis, 1-2 views | Office | 2022 | 14 | 14 | $714.00 | $287.49 | 40.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 13 | 16 | $640.00 | $198.08 | 31.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 27 | 170 | $680.00 | $149.94 | 22.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 14 | 45 | $225.00 | $17.90 | 8.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 173 | $41,093 | $16,002 | 38.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 43 | 53 | $14,999 | $7,308 | 48.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 49 | 49 | $15,917 | $6,084 | 38.2% |
About Dr. Keisha Maloney, MD
Dr. Keisha Maloney, MD is a Internal Medicine healthcare provider based in Covington, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992996540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keisha Maloney, MD has received a total of $10,206 in payments from pharmaceutical and medical device companies, with $1,170 received in 2024. These payments were reported across 533 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,917).
As a Medicare-enrolled provider, Maloney has provided services to 1,453 Medicare beneficiaries, totaling 2,448 services with total Medicare billing of $167,335. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Rheumatology
- Location Covington, GA
- Active Since 08/08/2007
- Last Updated 05/31/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992996540
Products in Payments
- RINVOQ (Biological) $920.80
- Enbrel (Biological) $870.31
- Cimzia (Drug) $797.05
- TREMFYA (Drug) $677.33
- KRYSTEXXA (Biological) $649.29
- SAPHNELO (Biological) $607.97
- ACTHAR (Biological) $447.70
- TALTZ (Drug) $411.01
- COSENTYX (Biological) $403.64
- XELJANZ (Drug) $395.07
- Rituxan (Biological) $303.92
- BENLYSTA (Biological) $294.96
- SIMPONI ARIA (Biological) $286.35
- ORENCIA (Biological) $226.04
- LUPKYNIS (Drug) $223.16
- Humira (Biological) $218.71
- EVENITY (Biological) $193.86
- KEVZARA (Drug) $174.93
- TAVNEOS (Drug) $173.35
- REMICADE (Biological) $172.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Covington
Bruce Samuels, Md, MD
Internal Medicine — Payments: $170,809
Dr. Lemuel Jenkins, M.d, M.D
Internal Medicine — Payments: $66,021
Dr. David Tran, M.d, M.D
Internal Medicine — Payments: $34,069
Frank Arena, M.d, M.D
Internal Medicine — Payments: $23,791
Dr. Elizabeth White, M.d, M.D
Internal Medicine — Payments: $21,159
Dr. Tania Levi, M.d, M.D
Internal Medicine — Payments: $13,070